Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
A variety of inherited or multifactorial ocular diseases call for novel treatment paradigms. The newly developed genome editing technology, CRISPR, has shown great promise in treating these diseases, but delivery of the CRISPR/Cas components to target ocular tissues and cells requires appropriate us...
Saved in:
Published in | Advanced drug delivery reviews Vol. 168; pp. 181 - 195 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!